Search company, investor...


Founded Year




Total Raised


About OBiO

Obio Technology (688238.SH) focuses on providing CRO services such as gene therapy vector development, gene function research and other basic research on gene therapy.

Headquarters Location

Building 19, Lane 908, Ziping Road, Pudong New Area

Shanghai, Shanghai,



Missing: OBiO's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: OBiO's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing OBiO

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

OBiO is included in 2 Expert Collections, including Regenerative Medicine.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

OBiO Patents

OBiO has filed 3 patents.

patents chart

Application Date

Grant Date


Related Topics




Alcohol abuse, EC 1.1.1, Drinking culture, Alcohol, Gastrointestinal tract disorders


Application Date


Grant Date



Related Topics

Alcohol abuse, EC 1.1.1, Drinking culture, Alcohol, Gastrointestinal tract disorders



Latest OBiO News

Celebrating Women Leaders Making a Difference in the Health Science Industry

Jan 11, 2023

Author of the article: Article content TORONTO — Following a competitive application process, the Ontario Bioscience Innovation Organization (OBIO®) is pleased to announce the eight successful awardees of the inaugural Women in Health Initiative’s (WiHI) Business Leadership Program (“Program”). We apologize, but this video has failed to load. Try refreshing your browser, or Celebrating Women Leaders Making a Difference in the Health Science Industry Back to video “OBIO’s Women in Health Initiative is designed to increase the participation and advancement of women in the health and life sciences sector,” said Dr. Maura Campbell, President & CEO of OBIO®. “This is especially critical at the leadership level where women can serve as role models, attract a more diverse workforce and change workplace policies to ensure greater inclusivity. This program supports the realization of these goals.” Advertisement 2 Article content Financial Post Top Stories Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc. Email Address Sign Up By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails or any newsletter. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300 Thanks for signing up! A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Financial Post Top Stories will soon be in your inbox. We encountered an issue signing you up. Please try again Article content More than 50 promising candidates from a range of early-stage Ontario life science companies developing therapeutics, medical devices, diagnostics or digital health technologies were considered. Each candidate was assessed based on their educational and professional background, their impact on their company, their contributions to the ecosystem and the skills and background they collectively bring to the Program. “It was a very difficult decision to select only eight recipients from this incredibly talented pool of individuals. We are looking at alternative ways to support all those who applied,” added Dr. Campbell. The successful applicants (each of whom receive a $50K wage subsidy) will participate in OBIO®’s networking events and contribute as mentor leaders to a community for women’s professional development, further supporting workforce development in a sector where women are underrepresented. The initiative is funded with support from the Government of Canada, through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario). “Increasing the involvement of women in the health and life sciences sector will diversify perspectives and ideas to increase innovation. With these eight award recipients, OBIO’s WiHI Business Leadership Program is demonstrating how investing in women’s potential can lead to a strong and diverse community. This in turn will contribute to a growing economy that works for everyone,” said the Honourable Filomena Tassi, Minister responsible for the Federal Economic Development Agency for Southern Ontario. “The Government of Canada congratulates the eight successful applicants, and we look forward to the amazing work you will develop and foster for years to come.” “The OBIO® Board and staff offer heartfelt congratulations to these eight talented women and commend all of those who applied to the Program,” said Dr. Campbell. To learn more about the awardees of the inaugural WiHI Business Leadership Program, click here . On Thursday, January 26 at the MaRS Discovery Centre in Toronto, OBIO® is hosting a networking session that includes a panel discussion featuring the Program awardees. For more information or to register, click here . About OBIO® Founded in 2009, OBIO® is a not-for-profit membership-based innovation organization engaged in strategy, programming, policy development and advocacy to further the commercialization of human health technologies that position Canada as a leader in the international marketplace. OBIO® advances this goal through collaborative partnerships with industry, the investment community, academia, the health care system and government. For more information, please visit and follow OBIO® on LinkedIn and Twitter . Advertisement 3 Article content About FedDev Ontario For 13 years, the Government of Canada, through FedDev Ontario , has worked to advance and diversify the southern Ontario economy through funding opportunities and business services that support innovation, growth and job creation in Canada’s most populous region. The Agency has delivered impressive results, which can be seen in southern Ontario businesses that are creating innovative technologies, improving productivity, growing revenues, creating jobs, and in the economic advancement of communities across the region. Learn more about the impacts the Agency is having in southern Ontario by exploring our pivotal projects , our Southern Ontario Spotlight , and FedDev Ontario’s Twitter , Facebook , Instagram and LinkedIn . View source version on Contacts

OBiO Frequently Asked Questions (FAQ)

  • When was OBiO founded?

    OBiO was founded in 2013.

  • Where is OBiO's headquarters?

    OBiO's headquarters is located at Building 19, Lane 908, Ziping Road, Pudong New Area, Shanghai.

  • What is OBiO's latest funding round?

    OBiO's latest funding round is IPO - II.

  • How much did OBiO raise?

    OBiO raised a total of $84.85M.

  • Who are the investors of OBiO?

    Investors of OBiO include Tencent Holdings, GP Capital, Loyal Valley Capital, Mount Morning Capital, Lingang Technology Investment and 16 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.